Arca Biopharma's market cap is currently ―. The company's EPS TTM is $-0.37; its P/E ratio is -9.86; Arca Biopharma is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -1.09M	$ -1.42M	$ -1.48M	$ -1.35M	$ -1.55M
EBITDA	$ -1.07M	-	$ -1.48M	$ -1.32M	-
Net Income Common Stockholders	$ -1.09M	$ -1.42M	$ -1.48M	$ -1.35M	$ -1.17M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 37.43M	$ 38.49M	$ 40.16M	$ 40.85M	$ 42.45M
Total Assets	$ 37.86M	$ 39.18M	$ 41.08M	$ 42.04M	$ 43.09M
Total Debt	$ 204.00K	$ 224.00K	$ 243.00K	$ 262.00K	$ 280.00K
Net Debt	$ -37.23M	$ -38.26M	$ -39.91M	$ -40.59M	$ -42.16M
Total Liabilities	$ 841.00K	$ 1.22M	$ 1.84M	$ 1.53M	$ 43.09M
Stockholders Equity	$ 37.02M	$ 37.97M	$ 39.24M	$ 40.53M	$ 41.67M
Cash Flow	-
Free Cash Flow	$ -1.06M	-	$ -1.48M	$ -1.59M	$ -1.49M
Operating Cash Flow	$ -1.06M	$ -1.67M	$ -1.48M	$ -1.59M	$ -1.49M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

Arca Biopharma Earnings and Revenue History

Income Statement >

Arca Biopharma Debt to Assets

Balance Sheet >

Arca Biopharma Cash Flow

Cash Flow >

Arca Biopharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing